TB-500/BPC-157 Blend

The TB-500/BPC-157 Blend combines two synthetic peptides intended for controlled laboratory research. BPC-157 is commonly investigated in preclinical studies involving cellular signalling and tissue-response pathways, while TB-500 is associated with a thymosin beta-4 fragment studied in areas such as actin regulation and cellular migration. Available evidence remains largely preclinical, with limited human safety data.

Product Features

• Dual-peptide research blend
• Suitable for controlled laboratory and analytical studies
• Supplied in a securely sealed and clearly labelled vial
• Useful for comparative peptide and cellular-pathway research
• Intended for handling by qualified research professionals

Storage

Store under the conditions stated on the product label or certificate of analysis. Keep the vial securely sealed and protected from excessive heat, moisture and direct sunlight.

Important Notice

Neither BPC-157 nor TB-500 is an FDA-approved medicine. The FDA states that human safety information is limited for BPC-157 and that it has identified no human-exposure data for the thymosin beta-4 fragment also known as TB-500. The agency also notes potential concerns involving immunogenicity, peptide impurities and product characterization.

For laboratory research purposes only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease.